BLCO - Bausch + Lomb Corp

13.66
-0.070   -0.512%

Share volume: 837,109
Last Updated: 04-28-2025
Medical Equipment/Ophthalmic Goods: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$13.73
-0.07
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 10%
Dept financing 32%
Liquidity 8%
Performance 61%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.66%
1 Month
-5.79%
3 Months
-23.60%
6 Months
-34.20%
1 Year
-9.66%
2 Year
-22.03%
Key data
Stock price
$13.66
P/E Ratio 
0.00
DAY RANGE
$13.42 - $13.97
EPS 
-$1.05
52 WEEK RANGE
$10.46 - $21.69
52 WEEK CHANGE
-$6.05
MARKET CAP 
6.360 B
YIELD 
N/A
SHARES OUTSTANDING 
352.027 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
0.54
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$682,098
AVERAGE 30 VOLUME 
$841,090
Company detail
CEO: Joseph C. Papa
Region: US
Website: bausch.com
Employees: 12,500
IPO year: 2022
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life.Our business was founded in 1853 and incorporated in the State of New York in 1908 (“Old Bausch + Lomb”). Our executive offices are located at 520 Applewood Crescent, Vaughan, Ontario, Canada.

Recent news
loading